Toll-like receptors (TLRs) play a pivotal role in inflammatory processes, and individual TLRs have been investigated in nociception. We examined overlapping and diverging roles of spinal TLRs and their associated adaptor proteins in nociceptive processing. Intrathecal (IT) TLR2, TLR3, or TLR4 ligands (-L) evoked persistent (7-day) tactile allodynia (TA) that was abolished in respective TLR-deficient mice. Using Tnf À/À mice, we found that IT TLR2 and TLR4 TA was tumor necrosis factor (TNF) dependent, whereas TLR3 was TNF-independent. In Toll-interleukin 1 receptor (TIR) domain-containing adaptor protein (TIRAP; Tirap domain-containing adaptor protein (TIRAP) and TRIF cascades differentially lead to robust TA by TNFdependent and independent pathways, whereas activation of TRIF modulated processing through type I IFN receptors. Based on these results, we believe that processes leading to the activation of these spinal TLRs initiate TNF-dependent and -independent cascades, which contribute to the associated persistent pain state. In addition, TRIF pathways are able to modulate the TNF-dependent pain state through IFNb. Ó
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Introduction
Innate immunity is involved in tissue-level responses to infection and injury. Elements of this process, notably the Toll-like receptors (TLRs), are expressed by glia [3, 4, 24] and neurons [33, 47] . TLRs have been implicated in the nociceptive processing initiated by inflammation and peripheral nerve injury [5, 9, 12, 32, 41, 55] . These observations, indicating a role for TLRs in these pain models in the absence of an infectious process, are in accord with observations that a variety of endogenous ligands known to activate TLRs have been identified in biologic systems and may serve to act through these constitutively expressed receptors [6, 13, 25, 35] . Several approaches have provided direct support for a role of spinal TLRs in pain processing. Thus, spinal (intrathecal [IT] ) delivery of TLR4 agonists yields nociception and allodynia [9, 10, 38, 51, 54] . Conversely, pharmacological blockade of spinal TLR4 attenuates evolution of a persistent pain state [9] . Additionally, delivery of agents that reduce glial activation can inhibit the facilitatory effects of IT TLR agonists [22, 39, 49, 51] .
There are 13 identified TLRs, some localized to the cell surface and others on endosomes, which signal through a limited number of adaptor proteins (Fig. 1A) . The Toll-interleukin 1 receptor (TIR) domain-containing adaptor protein (TIRAP) is exclusive to TLR2 and TLR4, and facilitates myeloid differentiation factor 88 (MyD88) activation [20, 21] . The MyD88 activation pathway, common to all TLRs except TLR3, leads to activation of Nuclear Factor kappaB (NF-jB), yielding production of proinflammatory cytokines such as tumor necrosis factor (TNF) and interleukin (IL)-1 [27] . In contrast, the TIR-domain-containing adapter-inducing interferonb (TRIF) is shared by TLR3 and TLR4 signaling, and skews to type I interferon production [16, 42] . Thus, TLR activation, through either the MyD88 or the TRIF pathways, can lead to a wide range of effects. Given this complex organization and the expression of TLRs by glia and neurons, the net effect of activating any 1 of the multiple spinal TLRs cannot be predicted in the absence of specific data on outcomes associated with defined spinal TLR activation.
